Clinical Trials Browser

Active not recruiting × Recurrence × cemiplimab × Clear all

NCT02651662 2026-02-02

CLIO-1

Phase 1 Active not recruiting

Recurrence, Lymphoma, B-Cell

NCT05662397 2025-02-04

A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Phase 1/2 Active not recruiting

Neoplasms, Recurrence